Namibia's academic appeal

I arrived in Windhoek, the capital city of Namibia, this morning, as part of a 10 day linkurl:trip to Africa;http://www.the-scientist.com/blog/display/23265/ on behalf of The Scientist to talk to researchers about the state of science on the continent. In no time, I was being whisked over to the linkurl:University of Namibia;http://www.unam.na/ by molecular biologist Kazhila Chinsembu. Chinsembu is originally from Zambia but has been at the University of Namibia for four years. As we drove t

Written byStephen Pincock
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share
I arrived in Windhoek, the capital city of Namibia, this morning, as part of a 10 day linkurl:trip to Africa;http://www.the-scientist.com/blog/display/23265/ on behalf of The Scientist to talk to researchers about the state of science on the continent. In no time, I was being whisked over to the linkurl:University of Namibia;http://www.unam.na/ by molecular biologist Kazhila Chinsembu. Chinsembu is originally from Zambia but has been at the University of Namibia for four years. As we drove through the clean, modern-looking city, he explained why.One of the main factors was stability, he said. Back in Zambia, the university had been closed down seven times in the seven years he worked there as a result of staffing problems, salary disputes, student unrest or political problems. In the four years he's been in Namibia there hasn't been a single closure.Another factor is the relatively good financial prospects in Namibia, which has been independent of linkurl:South Africa;http://www.the-scientist.com/blog/display/23266/ for the past 16 years. In Zambia, his monthly salary was about US$400 a month; now it is more like $2,500.On top of all this, Namibia is one of the few countries in Africa where people with jobs can get hold of mortgages to buy houses, and car loans. All in all, its an attractive place, which might explain why roughly three-quarters of the University of Namibia's academic staff is from elsewhere in Africa. The country is drawing professional people in like bees to a honey-pot.But not all is sweet for the country's scientists. The university's head of biology, Godwin Kaaya (from Tanzania) explained that research funds are almost non-existent. For the whole university the annual research budget is in the region of one million Namibian dollars, or US$142,000. That's the whole university.What this means for scientists is a lack of equipment and all the obvious results. For many of them it is a case of keeping their research careers going by hook and crook, while applying for funds from donor agencies in the world at large.
Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Meet the Author

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies